FLT3 and neoplasm: Additionally, miR-16 was found to be down-regulated in FLT3-ITD positive murine myeloid FDC-P1 cells and FLT3 inhibition tends to correct this down-regulation, therefore suggesting a tumor suppressor activity in FLT3/ITD-mediated leukemic transformation (57, 58).